Literature DB >> 22966046

Escherichia coli isolates that carry vat, fyuA, chuA, and yfcV efficiently colonize the urinary tract.

Rachel R Spurbeck1, Paul C Dinh, Seth T Walk, Ann E Stapleton, Thomas M Hooton, Lisa K Nolan, Kwang Sik Kim, James R Johnson, Harry L T Mobley.   

Abstract

Extraintestinal Escherichia coli (ExPEC), a heterogeneous group of pathogens, encompasses avian, neonatal meningitis, and uropathogenic E. coli strains. While several virulence factors are associated with ExPEC, there is no core set of virulence factors that can be used to definitively differentiate these pathotypes. Here we describe a multiplex of four virulence factor-encoding genes, yfcV, vat, fyuA, and chuA, highly associated with uropathogenic E. coli strains that can distinguish three groups of E. coli: diarrheagenic and animal-associated E. coli strains, human commensal and avian pathogenic E. coli strains, and uropathogenic and neonatal meningitis E. coli strains. Furthermore, human intestinal isolates that encode all four predictor genes express them during exponential growth in human urine and colonize the bladder in the mouse model of ascending urinary tract infection in higher numbers than human commensal strains that do not encode the four predictor genes (P = 0.02), suggesting that the presence of the predictors correlates with uropathogenic potential.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22966046      PMCID: PMC3497434          DOI: 10.1128/IAI.00752-12

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  40 in total

1.  Genetic and phenotypic analysis of Escherichia coli with enteropathogenic characteristics isolated from Seattle children.

Authors:  T N Bokete; T S Whittam; R A Wilson; C R Clausen; C M O'Callahan; S L Moseley; T R Fritsche; P I Tarr
Journal:  J Infect Dis       Date:  1997-06       Impact factor: 5.226

2.  Urovirulence determinants in Escherichia coli isolates causing first-episode and recurrent cystitis in women.

Authors:  A Stapleton; S Moseley; W E Stamm
Journal:  J Infect Dis       Date:  1991-04       Impact factor: 5.226

3.  Genetic diversity and relationships among strains of Escherichia coli in the intestine and those causing urinary tract infections.

Authors:  D A Caugant; B R Levin; G Lidin-Janson; T S Whittam; C Svanborg Edén; R K Selander
Journal:  Prog Allergy       Date:  1983

4.  Standard reference strains of Escherichia coli from natural populations.

Authors:  H Ochman; R K Selander
Journal:  J Bacteriol       Date:  1984-02       Impact factor: 3.490

5.  Secretor state and renal scarring in girls with recurrent pyelonephritis.

Authors:  H Lomberg; M Hellström; U Jodal; C Svanborg Eden
Journal:  FEMS Microbiol Immunol       Date:  1989-06

6.  Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains.

Authors:  H L Mobley; D M Green; A L Trifillis; D E Johnson; G R Chippendale; C V Lockatell; B D Jones; J W Warren
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

7.  Adherence of enterohemorrhagic Escherichia coli strains to a human colonic epithelial cell line (T84).

Authors:  D K Winsor; S Ashkenazi; R Chiovetti; T G Cleary
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

8.  Virulence of Yersinia enterocolitica is closely associated with siderophore production, expression of an iron-repressible outer membrane polypeptide of 65,000 Da and pesticin sensitivity.

Authors:  J Heesemann; K Hantke; T Vocke; E Saken; A Rakin; I Stojiljkovic; R Berner
Journal:  Mol Microbiol       Date:  1993-04       Impact factor: 3.501

9.  A randomized, controlled trial of cefoperazone vs. cefamandole-tobramycin in the treatment of putative, severe infections with gram-negative bacilli.

Authors:  J W Warren; E H Miller; B Fitzpatrick; D E DiFranco; E S Caplan; J H Tenney; W C Anthony
Journal:  Rev Infect Dis       Date:  1983 Mar-Apr

10.  The link between phylogeny and virulence in Escherichia coli extraintestinal infection.

Authors:  B Picard; J S Garcia; S Gouriou; P Duriez; N Brahimi; E Bingen; J Elion; E Denamur
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

View more
  82 in total

1.  Lipocalin 2 imparts selective pressure on bacterial growth in the bladder and is elevated in women with urinary tract infection.

Authors:  Magnus Steigedal; Anne Marstad; Markus Haug; Jan K Damås; Roland K Strong; Pacita L Roberts; Stephanie D Himpsl; Ann Stapleton; Thomas M Hooton; Harry L T Mobley; Thomas R Hawn; Trude H Flo
Journal:  J Immunol       Date:  2014-11-14       Impact factor: 5.422

2.  Regulation of Expression of Uropathogenic Escherichia coli Nonfimbrial Adhesin TosA by PapB Homolog TosR in Conjunction with H-NS and Lrp.

Authors:  Michael D Engstrom; Harry L T Mobley
Journal:  Infect Immun       Date:  2016-01-11       Impact factor: 3.441

3.  Extended-Spectrum-β-Lactamase- and Plasmid AmpC-Producing Escherichia coli Causing Community-Onset Bloodstream Infection: Association of Bacterial Clones and Virulence Genes with Septic Shock, Source of Infection, and Recurrence.

Authors:  Inga Fröding; Badrul Hasan; Isak Sylvin; Maarten Coorens; Pontus Nauclér; Christian G Giske
Journal:  Antimicrob Agents Chemother       Date:  2020-07-22       Impact factor: 5.191

4.  Blocking yersiniabactin import attenuates extraintestinal pathogenic Escherichia coli in cystitis and pyelonephritis and represents a novel target to prevent urinary tract infection.

Authors:  Ariel R Brumbaugh; Sara N Smith; Sargurunathan Subashchandrabose; Stephanie D Himpsl; Tracy H Hazen; David A Rasko; Harry L T Mobley
Journal:  Infect Immun       Date:  2015-01-26       Impact factor: 3.441

5.  The high prevalence of serine protease autotransporters of Enterobacteriaceae (SPATEs) in Escherichia coli causing neonatal septicemia.

Authors:  R Tapader; S Chatterjee; A K Singh; P Dayma; S Haldar; A Pal; S Basu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-06-13       Impact factor: 3.267

6.  UTI patients have pre-existing antigen-specific antibody titers against UTI vaccine antigens.

Authors:  Christina A Sarkissian; Christopher J Alteri; Harry L T Mobley
Journal:  Vaccine       Date:  2019-07-15       Impact factor: 3.641

7.  Immunization with the yersiniabactin receptor, FyuA, protects against pyelonephritis in a murine model of urinary tract infection.

Authors:  Ariel R Brumbaugh; Sara N Smith; Harry L T Mobley
Journal:  Infect Immun       Date:  2013-06-24       Impact factor: 3.441

8.  The Locus of Heat Resistance Confers Resistance to Chlorine and Other Oxidizing Chemicals in Escherichia coli.

Authors:  Zhiying Wang; Yuan Fang; Shuai Zhi; David J Simpson; Alexander Gill; Lynn M McMullen; Norman F Neumann; Michael G Gänzle
Journal:  Appl Environ Microbiol       Date:  2020-02-03       Impact factor: 4.792

9.  Zoonotic potential of Escherichia coli isolates from retail chicken meat products and eggs.

Authors:  Natalie M Mitchell; James R Johnson; Brian Johnston; Roy Curtiss; Melha Mellata
Journal:  Appl Environ Microbiol       Date:  2014-12-05       Impact factor: 4.792

10.  A conserved PapB family member, TosR, regulates expression of the uropathogenic Escherichia coli RTX nonfimbrial adhesin TosA while conserved LuxR family members TosE and TosF suppress motility.

Authors:  Michael D Engstrom; Christopher J Alteri; Harry L T Mobley
Journal:  Infect Immun       Date:  2014-06-16       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.